Cristian A. Ferri

, Ruta 12, Km 7.5, C.P, 3300, Miguel Lanús
Posadas, N, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Expression patterns of PIK3CA and PTEN in cancer and type 2 diabetes mellitus.

Expression patterns of PIK3CA and PTEN in cancer and type 2 diabetes mellitus.

Journal: Gene

Published: June 16, 2025

Expression of genes potentially involved in loss of response in patients with chronic myeloid leukemia.

Expression of genes potentially involved in loss of response in patients with chronic myeloid leukemia.

Journal: Gene

Published: July 19, 2023

The dynamic of TNF and IL6 gene expression in chronic myeloid leukemia patients reveals early responders to imatinib.

The dynamic of TNF and IL6 gene expression in chronic myeloid leukemia patients reveals early responders to imatinib.

Journal: Leukemia research

Published: March 25, 2019

Single nucleotide polymorphism in PTEN-Long gene: A risk factor in chronic myeloid leukemia.

Single nucleotide polymorphism in PTEN-Long gene: A risk factor in chronic myeloid leukemia.

Journal: Gene

Published: December 18, 2018

Asymptomatic dengue virus cases in misiones, Argentina: a seroprevalence study in the university population.

Asymptomatic dengue virus cases in misiones, Argentina: a seroprevalence study in the university population.

Journal: Microbes and infection

Published: April 19, 2018

GSTM1 and GSTP1, but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response.

GSTM1 and GSTP1, but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response.

Journal: Cancer epidemiology

Published: April 08, 2016

TP53 codon 72 polymorphism predicts chronic myeloid leukemia susceptibility and treatment outcome.

TP53 codon 72 polymorphism predicts chronic myeloid leukemia susceptibility and treatment outcome.

Journal: Blood cells, molecules & diseases

Published: March 29, 2016

Clinical activity of ponatinib in one patient with chronic myeloid leukemia in chronic phase with e19a2 transcript and T315I mutation.

Clinical activity of ponatinib in one patient with chronic myeloid leukemia in chronic phase with e19a2 transcript and T315I mutation.

Journal: European journal of haematology

Published: April 22, 2014

CAMKIIγ, HSP70 and HSP90 transcripts are differentially expressed in chronic myeloid leukemia cells from patients with resistant mutated disease.

CAMKIIγ, HSP70 and HSP90 transcripts are differentially expressed in chronic myeloid leukemia cells from patients with resistant mutated disease.

Journal: Leukemia & lymphoma

Published: November 12, 2013

New mutation L324M in the ABL1 kinase domain: does it confer high resistance to second-generation inhibitors?

New mutation L324M in the ABL1 kinase domain: does it confer high resistance to second-generation inhibitors?

Journal: Leukemia & lymphoma

Published: June 08, 2013

Expression of LYN and PTEN genes in chronic myeloid leukemia and their importance in therapeutic strategy.

Expression of LYN and PTEN genes in chronic myeloid leukemia and their importance in therapeutic strategy.

Journal: Blood cells, molecules & diseases

Published: February 04, 2013

Early detection and quantification of mutations in the tyrosine kinase domain of chimerical BCR-ABL1 gene combining high-resolution melting analysis and mutant-allele specific quantitative polymerase chain reaction.

Early detection and quantification of mutations in the tyrosine kinase domain of chimerical BCR-ABL1 gene combining high-resolution melting analysis and mutant-allele specific quantitative polymerase chain reaction.

Journal: Leukemia & lymphoma

Published: August 09, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026